breast cancer
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: postmenopausal woman with breast cancer, patient who has administered intramuscularly fulvestrant treatment more than three months, person who agrees to participate this study
Exclusion criteria
Exclusion criteria: person who complicated metastasis to bone and lung, person with skin diseases and the induration of the injection site in the buttocks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| muscle hardness | — |
Secondary
| Measure | Time frame |
|---|---|
| skin reaction in the site of the hot compress, degree of comfort and unpleasantness by the hot compress, time of injecting the medication, difficulty of depressing the syringe plunger in injecting | — |
Countries
Japan
Contacts
University of Human Environments Graduate School of Nursing Doctor of Nursing Programs